Tuberculosis: Top Cause of Death Among PLHIV
In the Philippines, tuberculosis is the primary cause of death among people living with human immunodeficiency virus (PLHIV), officials reported. One in every five deaths among PLHIV is linked to tuberculosis, underscoring the urgent need for early detection and treatment.
Health authorities emphasize that tuberculosis poses a high risk to PLHIV due to their weakened immune systems. Without prompt intervention, the disease can cause severe complications or even prove fatal.
Current HIV and TB Case Statistics
From January to March 2025, sources said more than 5,000 newly diagnosed PLHIV cases were recorded nationwide. On average, 57 new HIV cases were confirmed daily during this period, highlighting the ongoing challenge of controlling the virus.
Meanwhile, community health experts noted that Southeast Asia recorded the highest number of new tuberculosis cases in 2023. Approximately 87 percent of these cases came from 30 countries with high TB burdens, including the Philippines.
Preventing HIV and TB Co-Infection
Officials stressed that co-infection of HIV and tuberculosis can be effectively prevented. Key measures include regular tuberculosis screening, adherence to continuous antiretroviral therapy (ART), and the use of Tuberculosis Preventive Treatment (TPT).
Public health workers urged those with family members diagnosed with TB to undergo TPT even if they show no symptoms. This preventive approach is crucial to curb the spread and impact of the disease.
Public Health Recommendations
The Department of Health advised the public to wear masks and seek medical consultation if a cough persists for more than two weeks. Parents were also encouraged to have their toddlers vaccinated with the Bacillus Calmette-Guerin (BCG) vaccine to protect against tuberculosis.
These steps are vital to reduce the risk of TB infection and safeguard the health of vulnerable populations, especially those living with HIV.
For more news and updates on tuberculosis and HIV, visit Filipinokami.com.